Cancer Treatment Demand at All-time High in MEA, Technetium-99m Included

Technetium-99m is a radioactive isotope of technetium, commonly used in the healthcare industry. Two of the most common applications of technetium-99m are in a gamma camera and for body imaging using SPECT. The latter is a high-sensitivity detection method for parathyroid adenomas within the human body, while a gamma camera can be used to generate bone marrow imaging and cardiac imaging. Technetium-99m is currently one of the more highly demanded radioisotopes in the world due to its uses in medicine. It can be created using molybdenum, which is in abundance across the world.

The Middle East and Africa technetium-99m market is expected to reach 636.1 mn by the end of 2026, after expanding at a brilliant CAGR of 8.1% within a forecast period from 2016 to 2026. The market was calculated to have reached US$273.3 mn at the end of 2015. Several factors are going into the growth of the MEA technetium-99m market, and the core factors for this market’s growth are explained below:

Obtain Report Details @

Are Player Advancements Occurring at a Satisfactory Rate?
One of the fundamental factors responsible for the growth of the MEA technetium-99m market at the moment is the swift rate of advancements in technology that are being brought into the region. This applies specially to imaging technologies, where there is a high usage of technetium-99m.

Key players in the MEA technetium-99m market, including Siemens Healthineers, General Electric Company, and Sumitomo Heavy Industries are primarily globally invested entities, and therefore their rate of research from any of their regional stations will result in the growing market share for technetium-99m in the MEA region. This can also be highlighted through medical recognition for the efforts that similar companies have made, including the reception of the Recognition Award by players from the U.S. Department of Energy’s NNSA, which was recently awarded to UPPI LLC.

What Will the MEA Demand for Technetium-99m Look Like in the Future?
The growing count of patients suffering from chronic diseases and non-communicable diseases in the Middle East and Africa region is increasing at a very swift rate, and both government and private healthcare organizations need to pick up the pace in order to respond to this growing demand for treatments. With both cancer and heart diseases on the rise in this region, hospitals and medical organizations are placing a special importance on treatment and development procedures. This includes the use of technetium-99m in imaging technologies, thereby propelling the growth of the MEA technetium-99m market.

This will likely be the scenario for the MEA region for the coming years as well, due to the reports shown by organizations such as the CDC and the WHO, both of whom have stated that the overall number of people suffering from chronic illnesses and heart disease is showing an inclined curve over the next few decades.


Post a Comment

Note: only a member of this blog may post a comment.

Latest Post

Market Research Reports